Edition 2018

International Optometrist of the Year Award 2018

On September 19, as part of the inauguration of the 2018-2019 academic year, the Faculty of Optics and Optometry of Terrassa presented Professor Konrad Pesudovs with the International Optometrist of the Year Award, 2018 edition.

During the event, held in the monumental complex of the Sant Pere Churches in Terrassa, one of the jewels of Romanesque architecture (9th–12th century), Professor Pesudovs delivered the inaugural lecture, aimed especially at first-year FOOT students, encouraging them to excel academically and personally, and to look beyond books to achieve clinical expertise and a balanced life philosophy.

The presentation of the Clinical Activity logbook was also held for second-year students, serving as documentation of the patients these students will have the opportunity to interact with throughout their degree.

Konrad Pesudovs

Foundation Professor Flinders University, PhD University of Melbourne

Professor at Flinders University, Adelaide. Researcher in outcomes ophthalmology, Chair of the Ophthalmology, Eye and Vision Research Group.

Professor Pesudovs has been Foundation Professor of Optometry and Vision Science at Flinders University in Adelaide, South Australia. He graduated from the University of Melbourne in 1990, and after two years in specialized contact lens practice, joined the Department of Ophthalmology at Flinders University, where he completed a PhD in 2000. During this time, he also managed a private practice in Glenelg, South Australia.

His main research areas include patient-centered optometry, visual quality, comprehensive evaluation of outcomes in ophthalmology, as well as ocular optics and visual performance.

Professor Pesudovs participates in several international projects, such as The Global Burden of Diseases Study and The Swedish National Cataract Register. He has published over 200 peer-reviewed articles, 7 book chapters, and more than 70 other publications, with over 200 international presentations and accumulated funding exceeding 9 million dollars.